메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한골다공증학회 OSTEOPOROSIS OSTEOPOROSIS 제9권 제3호
발행연도
2011.1
수록면
238 - 243 (6page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Objectives: There is a lack of data on bone loss in premenopausal patients with breast cancer after chemotherapy in Korea. In this study, we compared the bone mineral density of breast cancer patients after chemotherapy with normal control. Materials and Methods: We used the data from the fourth Korea National Health and Nutrition Examination Survey (KNHNES) as normal control, and 119 women were enrolled who had surgery and chemotherapy due to breast cancer. They were under the age of 50 and premenopausal state according to their FSH level. Bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry. Results: T-score at Lumbar spine BMD was not different between breast cancer group and control group (0.16±0.98 vs 0.08±1.00, P=0.451). And neither did T-score at femoral neck (-0.18±1.09 vs -0.27±0.95, P=0.419). T-score at total hip BMD was significantly different between two groups (0.26±0.97 vs 0.64±0.91, P<0.001). After adjustment of age and body mass index, the significance still remained (P<0.001 and P=0.001, respectively). The prevalence of bone loss (osteopenia and osteoporosis) at total hip was higher in breast cancer group than control group (10.1% vs 5.5%, P=0.012)Conclusions: The patients with breast cancer needs to evaluate the bone mineral density at total hip even if they are premenopausal states.

목차

등록된 정보가 없습니다.

참고문헌 (15)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0